Scarica l'app Stockscreener
26.38
6.59%
1.63
Dopo l'orario di chiusura:
26.71
0.33
+1.25%
Precedente Chiudi:
$24.75
Aprire:
$24.06
Volume 24 ore:
8.57M
Relative Volume:
1.73
Capitalizzazione di mercato:
$13.11B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
65.95
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+6.11%
1M Prestazione:
+8.11%
6M Prestazione:
+47.29%
1 anno Prestazione:
+137.44%
Intervallo 1D:
$23.53
$26.87
Intervallo di 1 settimana:
$23.53
$26.87
Portata 52W:
$8.02
$26.87
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
26.38 | 12.30B | 4.45B | 205.00M | 372.00M | 0.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.65 | 59.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.66 | 53.10B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.08 | 49.34B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.92 | 39.49B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.43 | 20.43B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus
Elanco (ELAN) Focuses on Growth through Innovation and Cash Flow Management - GuruFocus
Elanco Animal Health Q4 Earnings Call Highlights - Yahoo Finance
Elanco Animal Health Inc (ELAN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
Elanco Animal Health (ELAN) Receives Outperform Rating with Rais - GuruFocus
Elanco Animal Health Shares Rise After Q4 Beat - marketscreener.com
Elanco Working To Enhance Tools To Address New World Screwworm - Southeast AgNET
Elanco Animal Health Incorporated Q4 2025 Earnings Call Summary - Yahoo Finance
Is Elanco Animal Health (ELAN) Still Attractive After A 123% One Year Share Price Jump - simplywall.st
Elanco (ELAN) Surges to 52-Week High on Strong Q4 Results - GuruFocus
Why Is Elanco (ELAN) Stock Soaring Today - Finviz
Elanco hits 52-week high after Q4 results as 2026 outlook beats consensus - Seeking Alpha
Elanco (NYSE:ELAN) Surprises With Q4 CY2025 Sales - Finviz
Elanco Q4 2025 Earnings Report & 2026 Financial Outlook | Animal HealthNews and Statistics - IndexBox
Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Elanco Animal Health Inc SEC 10-K Report - TradingView
Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Elanco (ELAN) Q4 Earnings Surpass Expectations with Strong Reven - GuruFocus
Elanco (ELAN) Surpasses Revenue Expectations and Forecasts Growt - GuruFocus
Elanco (ELAN) Projects Strong Financial Growth by FY26 - GuruFocus
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results - TradingView
(ELAN) Elanco Animal Health Incorporated Expects Q1 Revenue Range $1.28B$1.31B - marketscreener.com
Elanco Animal Health beats Q4 revenue estimates, raises FY innovation revenue target - TradingView
Pet Medical Equipment Market Is Going to Boom | Boehringer Ingelheim • Elanco Animal Health • Neogen Corporation - openPR.com
Animal Stem Cell Therapy Market to Expand at 5% CAGR by 2031, - openPR.com
Where is Elanco Animal Health Incorporated (ELAN) Headed According to the Street? - Finviz
Elanco Animal Health (ELAN) Stock Analysis: Exploring a Strong Upside with a 10.4% Revenue Growth - DirectorsTalk Interviews
Elanco Animal Health earnings on deck as dermatology bet looms By Investing.com - Investing.com Canada
What To Expect From Elanco's (ELAN) Q4 Earnings - Finviz
What To Expect From Elanco’s (ELAN) Q4 Earnings - Yahoo Finance
Meme Stocks: What is the Moat Score of Elanco Animal Health IncorporatedJuly 2025 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Jupiter Asset Management Ltd. Purchases 1,846,907 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Animal Antibiotics Market Growth Report: Industry Dynamics, - openPR.com
4 Analysts Assess Elanco Animal Health: What You Need To Know - Benzinga
Published on: 2026-02-19 21:49:34 - mfd.ru
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
JP Morgan Raises Price Target for Elanco Animal Health (ELAN) to $28.00 | ELAN Stock News - GuruFocus
Countdown to Elanco Animal Health (ELAN) Q4 Earnings: Wall Street Forecasts for Key Metrics - Yahoo Finance
Elanco to Participate in Upcoming Investor Conferences - Finviz
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - Reuters
Veterinary Medicine Market Booming with Rapid Growth Through 2033 | Ceva, Zoetis, Elanco - openPR.com
Companion Animal Health Market Set for Explosive Growth to US$ - openPR.com
Animal Performance Enhancers Market Forecast Through - openPR.com
Aug Volume: Will Elanco Animal Health Incorporated stock recover after earningsTrade Entry Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
MSN Money - MSN
Northwestern Mutual Investment Management Company LLC Buys Shares of 110,738 Elanco Animal Health Incorporated $ELAN - MarketBeat
Illinois Municipal Retirement Fund Sells 100,254 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (ELAN) to Release Earnings on Tuesday - MarketBeat
Board Exits at Elanco (ELAN) Raise a Quiet Question About Future Innovation and Oversight Balance - Yahoo Finance
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4 - MSN
Will Elanco Animal Health Incorporated (5EA) stock benefit from sector leadershipEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.01%
4.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):